nodes	percent_of_prediction	percent_of_DWPC	metapath
Mafenide—CA9—kidney cancer	0.433	0.527	CbGaD
Mafenide—CA2—kidney cancer	0.389	0.474	CbGaD
Mafenide—CA2—collecting duct of renal tubule—kidney cancer	0.00912	0.439	CbGeAlD
Mafenide—CA6—Reversible hydration of carbon dioxide—CA2—kidney cancer	0.00781	0.0913	CbGpPWpGaD
Mafenide—CA7—Reversible hydration of carbon dioxide—CA2—kidney cancer	0.00729	0.0852	CbGpPWpGaD
Mafenide—CA12—Reversible hydration of carbon dioxide—CA2—kidney cancer	0.00676	0.0789	CbGpPWpGaD
Mafenide—CA6—Reversible hydration of carbon dioxide—CA9—kidney cancer	0.00592	0.0692	CbGpPWpGaD
Mafenide—CA7—Reversible hydration of carbon dioxide—CA9—kidney cancer	0.00553	0.0646	CbGpPWpGaD
Mafenide—CA12—Reversible hydration of carbon dioxide—CA9—kidney cancer	0.00512	0.0598	CbGpPWpGaD
Mafenide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EPAS1—kidney cancer	0.0051	0.0595	CbGpPWpGaD
Mafenide—CA9—Reversible hydration of carbon dioxide—CA2—kidney cancer	0.00435	0.0509	CbGpPWpGaD
Mafenide—CA2—Reversible hydration of carbon dioxide—CA9—kidney cancer	0.00391	0.0457	CbGpPWpGaD
Mafenide—Disseminated intravascular coagulation—Sunitinib—kidney cancer	0.00312	0.0455	CcSEcCtD
Mafenide—Tachypnoea—Gemcitabine—kidney cancer	0.00261	0.0382	CcSEcCtD
Mafenide—Acidosis—Everolimus—kidney cancer	0.00241	0.0351	CcSEcCtD
Mafenide—CA7—renal system—kidney cancer	0.00239	0.115	CbGeAlD
Mafenide—CA7—kidney—kidney cancer	0.00231	0.111	CbGeAlD
Mafenide—CA9—Cellular response to hypoxia—VHL—kidney cancer	0.00225	0.0263	CbGpPWpGaD
Mafenide—CA9—Cellular response to hypoxia—EPAS1—kidney cancer	0.00225	0.0263	CbGpPWpGaD
Mafenide—CA9—Cellular response to hypoxia—TCEB2—kidney cancer	0.00197	0.023	CbGpPWpGaD
Mafenide—CA9—Cellular response to hypoxia—TCEB1—kidney cancer	0.00197	0.023	CbGpPWpGaD
Mafenide—Blister—Erlotinib—kidney cancer	0.00178	0.026	CcSEcCtD
Mafenide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—kidney cancer	0.00161	0.0188	CbGpPWpGaD
Mafenide—CA12—renal system—kidney cancer	0.00155	0.0747	CbGeAlD
Mafenide—Blister—Sunitinib—kidney cancer	0.00154	0.0225	CcSEcCtD
Mafenide—CA12—kidney—kidney cancer	0.0015	0.0722	CbGeAlD
Mafenide—Swelling—Temsirolimus—kidney cancer	0.00147	0.0215	CcSEcCtD
Mafenide—Bone marrow depression—Vincristine—kidney cancer	0.00139	0.0204	CcSEcCtD
Mafenide—Dermatitis bullous—Temsirolimus—kidney cancer	0.00136	0.0199	CcSEcCtD
Mafenide—Face oedema—Temsirolimus—kidney cancer	0.00126	0.0183	CcSEcCtD
Mafenide—Face oedema—Pazopanib—kidney cancer	0.00118	0.0173	CcSEcCtD
Mafenide—Sulfanilamide—CA9—kidney cancer	0.00115	0.386	CrCbGaD
Mafenide—Haemolytic anaemia—Erlotinib—kidney cancer	0.00103	0.0151	CcSEcCtD
Mafenide—Sulfanilamide—CA2—kidney cancer	0.00103	0.347	CrCbGaD
Mafenide—CA9—HIF-1-alpha transcription factor network—PGK1—kidney cancer	0.000992	0.0116	CbGpPWpGaD
Mafenide—Dermatitis bullous—Erlotinib—kidney cancer	0.000976	0.0143	CcSEcCtD
Mafenide—CA9—HIF-1-alpha transcription factor network—NDRG1—kidney cancer	0.000922	0.0108	CbGpPWpGaD
Mafenide—Bone marrow depression—Capecitabine—kidney cancer	0.000909	0.0133	CcSEcCtD
Mafenide—CA2—nephron tubule—kidney cancer	0.000877	0.0422	CbGeAlD
Mafenide—Haemoglobin—Pazopanib—kidney cancer	0.000852	0.0124	CcSEcCtD
Mafenide—Blister—Capecitabine—kidney cancer	0.000851	0.0124	CcSEcCtD
Mafenide—Haemorrhage—Pazopanib—kidney cancer	0.000847	0.0124	CcSEcCtD
Mafenide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—kidney cancer	0.000847	0.00989	CbGpPWpGaD
Mafenide—Dermatitis bullous—Sunitinib—kidney cancer	0.000845	0.0123	CcSEcCtD
Mafenide—CA2—renal system—kidney cancer	0.000797	0.0383	CbGeAlD
Mafenide—Pancytopenia—Vinblastine—kidney cancer	0.000797	0.0116	CcSEcCtD
Mafenide—Pancytopenia—Everolimus—kidney cancer	0.000794	0.0116	CcSEcCtD
Mafenide—Erythema—Temsirolimus—kidney cancer	0.000783	0.0114	CcSEcCtD
Mafenide—Face oedema—Sunitinib—kidney cancer	0.00078	0.0114	CcSEcCtD
Mafenide—CA2—kidney—kidney cancer	0.00077	0.0371	CbGeAlD
Mafenide—CA2—cortex of kidney—kidney cancer	0.00075	0.0361	CbGeAlD
Mafenide—Erythema—Pazopanib—kidney cancer	0.000738	0.0108	CcSEcCtD
Mafenide—CA2—cardiac atrium—kidney cancer	0.000714	0.0343	CbGeAlD
Mafenide—CA9—Cellular response to hypoxia—HIF1A—kidney cancer	0.00071	0.00829	CbGpPWpGaD
Mafenide—Dermatitis bullous—Gemcitabine—kidney cancer	0.000678	0.00991	CcSEcCtD
Mafenide—Haemoglobin—Vinblastine—kidney cancer	0.000675	0.00986	CcSEcCtD
Mafenide—Haemoglobin—Everolimus—kidney cancer	0.000672	0.00982	CcSEcCtD
Mafenide—Haemorrhage—Vinblastine—kidney cancer	0.000672	0.00981	CcSEcCtD
Mafenide—Haemorrhage—Everolimus—kidney cancer	0.000669	0.00977	CcSEcCtD
Mafenide—Pancytopenia—Sunitinib—kidney cancer	0.000663	0.00968	CcSEcCtD
Mafenide—Haemoglobin—Erlotinib—kidney cancer	0.000649	0.00948	CcSEcCtD
Mafenide—Haemorrhage—Erlotinib—kidney cancer	0.000646	0.00943	CcSEcCtD
Mafenide—Pancytopenia—Dactinomycin—kidney cancer	0.000628	0.00917	CcSEcCtD
Mafenide—Face oedema—Gemcitabine—kidney cancer	0.000626	0.00914	CcSEcCtD
Mafenide—Swelling—Paclitaxel—kidney cancer	0.000615	0.00898	CcSEcCtD
Mafenide—Bone marrow depression—Doxorubicin—kidney cancer	0.000586	0.00856	CcSEcCtD
Mafenide—Haemoglobin—Sorafenib—kidney cancer	0.000584	0.00853	CcSEcCtD
Mafenide—Erythema—Everolimus—kidney cancer	0.000582	0.00851	CcSEcCtD
Mafenide—Haemorrhage—Sorafenib—kidney cancer	0.000581	0.00848	CcSEcCtD
Mafenide—Hyperventilation—Doxorubicin—kidney cancer	0.000575	0.00839	CcSEcCtD
Mafenide—Burning sensation—Doxorubicin—kidney cancer	0.000569	0.00831	CcSEcCtD
Mafenide—Erythema—Erlotinib—kidney cancer	0.000562	0.00821	CcSEcCtD
Mafenide—Haemoglobin—Sunitinib—kidney cancer	0.000562	0.0082	CcSEcCtD
Mafenide—Pancytopenia—Vincristine—kidney cancer	0.000561	0.00819	CcSEcCtD
Mafenide—Haemorrhage—Sunitinib—kidney cancer	0.000559	0.00816	CcSEcCtD
Mafenide—Blister—Doxorubicin—kidney cancer	0.000549	0.00801	CcSEcCtD
Mafenide—Pain—Temsirolimus—kidney cancer	0.000546	0.00798	CcSEcCtD
Mafenide—Pancytopenia—Gemcitabine—kidney cancer	0.000532	0.00777	CcSEcCtD
Mafenide—Pain—Pazopanib—kidney cancer	0.000515	0.00752	CcSEcCtD
Mafenide—Erythema—Sorafenib—kidney cancer	0.000506	0.00738	CcSEcCtD
Mafenide—Dapsone—PTGS1—kidney cancer	0.000506	0.17	CrCbGaD
Mafenide—CA9—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	0.000505	0.0059	CbGpPWpGaD
Mafenide—Swelling—Capecitabine—kidney cancer	0.000505	0.00737	CcSEcCtD
Mafenide—Haemolytic anaemia—Capecitabine—kidney cancer	0.000493	0.0072	CcSEcCtD
Mafenide—Erythema—Sunitinib—kidney cancer	0.000487	0.00711	CcSEcCtD
Mafenide—Dermatitis bullous—Capecitabine—kidney cancer	0.000466	0.00681	CcSEcCtD
Mafenide—Erythema—Dactinomycin—kidney cancer	0.000461	0.00673	CcSEcCtD
Mafenide—Pruritus—Temsirolimus—kidney cancer	0.000452	0.0066	CcSEcCtD
Mafenide—Haemoglobin—Gemcitabine—kidney cancer	0.000451	0.00658	CcSEcCtD
Mafenide—Haemorrhage—Gemcitabine—kidney cancer	0.000448	0.00655	CcSEcCtD
Mafenide—Pancytopenia—Paclitaxel—kidney cancer	0.000445	0.00651	CcSEcCtD
Mafenide—Diarrhoea—Temsirolimus—kidney cancer	0.000437	0.00639	CcSEcCtD
Mafenide—Face oedema—Capecitabine—kidney cancer	0.00043	0.00628	CcSEcCtD
Mafenide—Pruritus—Pazopanib—kidney cancer	0.000426	0.00622	CcSEcCtD
Mafenide—Diarrhoea—Pazopanib—kidney cancer	0.000412	0.00602	CcSEcCtD
Mafenide—Pain—Vinblastine—kidney cancer	0.000408	0.00596	CcSEcCtD
Mafenide—Pain—Everolimus—kidney cancer	0.000407	0.00594	CcSEcCtD
Mafenide—Rash—Temsirolimus—kidney cancer	0.000403	0.00588	CcSEcCtD
Mafenide—Dermatitis—Temsirolimus—kidney cancer	0.000403	0.00588	CcSEcCtD
Mafenide—CA9—HIF-1-alpha transcription factor network—ABCB1—kidney cancer	0.000399	0.00466	CbGpPWpGaD
Mafenide—Pain—Erlotinib—kidney cancer	0.000392	0.00573	CcSEcCtD
Mafenide—Erythema—Gemcitabine—kidney cancer	0.00039	0.0057	CcSEcCtD
Mafenide—Rash—Pazopanib—kidney cancer	0.00038	0.00554	CcSEcCtD
Mafenide—Dermatitis—Pazopanib—kidney cancer	0.000379	0.00554	CcSEcCtD
Mafenide—Haemoglobin—Paclitaxel—kidney cancer	0.000377	0.00551	CcSEcCtD
Mafenide—Haemorrhage—Paclitaxel—kidney cancer	0.000375	0.00548	CcSEcCtD
Mafenide—CA9—Cellular response to hypoxia—VEGFA—kidney cancer	0.000374	0.00437	CbGpPWpGaD
Mafenide—Pancytopenia—Capecitabine—kidney cancer	0.000366	0.00534	CcSEcCtD
Mafenide—CA9—Cellular responses to stress—IGFBP7—kidney cancer	0.000358	0.00418	CbGpPWpGaD
Mafenide—Pain—Sorafenib—kidney cancer	0.000353	0.00515	CcSEcCtD
Mafenide—CA9—Cellular responses to stress—VHL—kidney cancer	0.000341	0.00399	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—EPAS1—kidney cancer	0.000341	0.00399	CbGpPWpGaD
Mafenide—Pain—Sunitinib—kidney cancer	0.00034	0.00496	CcSEcCtD
Mafenide—Pruritus—Everolimus—kidney cancer	0.000336	0.00491	CcSEcCtD
Mafenide—Urticaria—Sorafenib—kidney cancer	0.000328	0.00479	CcSEcCtD
Mafenide—Erythema—Paclitaxel—kidney cancer	0.000327	0.00477	CcSEcCtD
Mafenide—Diarrhoea—Vinblastine—kidney cancer	0.000327	0.00477	CcSEcCtD
Mafenide—CA9—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	0.000326	0.00381	CbGpPWpGaD
Mafenide—Diarrhoea—Everolimus—kidney cancer	0.000325	0.00475	CcSEcCtD
Mafenide—Pruritus—Erlotinib—kidney cancer	0.000325	0.00474	CcSEcCtD
Mafenide—Pain—Dactinomycin—kidney cancer	0.000321	0.00469	CcSEcCtD
Mafenide—Diarrhoea—Erlotinib—kidney cancer	0.000314	0.00458	CcSEcCtD
Mafenide—Haemoglobin—Capecitabine—kidney cancer	0.00031	0.00452	CcSEcCtD
Mafenide—Haemorrhage—Capecitabine—kidney cancer	0.000308	0.0045	CcSEcCtD
Mafenide—Dermatitis bullous—Doxorubicin—kidney cancer	0.0003	0.00439	CcSEcCtD
Mafenide—Rash—Everolimus—kidney cancer	0.0003	0.00438	CcSEcCtD
Mafenide—Dermatitis—Everolimus—kidney cancer	0.000299	0.00437	CcSEcCtD
Mafenide—CA9—Cellular responses to stress—TCEB2—kidney cancer	0.000299	0.0035	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—TCEB1—kidney cancer	0.000299	0.0035	CbGpPWpGaD
Mafenide—Pruritus—Sorafenib—kidney cancer	0.000292	0.00426	CcSEcCtD
Mafenide—Rash—Erlotinib—kidney cancer	0.000289	0.00422	CcSEcCtD
Mafenide—Dapsone—PTGS2—kidney cancer	0.000289	0.0971	CrCbGaD
Mafenide—Dermatitis—Erlotinib—kidney cancer	0.000289	0.00422	CcSEcCtD
Mafenide—Pain—Vincristine—kidney cancer	0.000287	0.00419	CcSEcCtD
Mafenide—Diarrhoea—Sorafenib—kidney cancer	0.000282	0.00412	CcSEcCtD
Mafenide—Pruritus—Sunitinib—kidney cancer	0.000281	0.0041	CcSEcCtD
Mafenide—Face oedema—Doxorubicin—kidney cancer	0.000277	0.00405	CcSEcCtD
Mafenide—Pain—Gemcitabine—kidney cancer	0.000272	0.00398	CcSEcCtD
Mafenide—Diarrhoea—Sunitinib—kidney cancer	0.000272	0.00397	CcSEcCtD
Mafenide—CA6—Metabolism—ACY1—kidney cancer	0.000269	0.00315	CbGpPWpGaD
Mafenide—Erythema—Capecitabine—kidney cancer	0.000268	0.00392	CcSEcCtD
Mafenide—Rash—Sorafenib—kidney cancer	0.00026	0.0038	CcSEcCtD
Mafenide—Dermatitis—Sorafenib—kidney cancer	0.00026	0.0038	CcSEcCtD
Mafenide—Diarrhoea—Dactinomycin—kidney cancer	0.000257	0.00376	CcSEcCtD
Mafenide—CA7—Metabolism—ACY1—kidney cancer	0.000251	0.00294	CbGpPWpGaD
Mafenide—Rash—Sunitinib—kidney cancer	0.00025	0.00366	CcSEcCtD
Mafenide—Dermatitis—Sunitinib—kidney cancer	0.00025	0.00365	CcSEcCtD
Mafenide—Eosinophilia—Doxorubicin—kidney cancer	0.000246	0.00359	CcSEcCtD
Mafenide—Rash—Dactinomycin—kidney cancer	0.000237	0.00346	CcSEcCtD
Mafenide—Pancytopenia—Doxorubicin—kidney cancer	0.000236	0.00344	CcSEcCtD
Mafenide—CA12—Metabolism—ACY1—kidney cancer	0.000233	0.00272	CbGpPWpGaD
Mafenide—Diarrhoea—Vincristine—kidney cancer	0.00023	0.00336	CcSEcCtD
Mafenide—CA6—Metabolism—PDHB—kidney cancer	0.000229	0.00268	CbGpPWpGaD
Mafenide—Pain—Paclitaxel—kidney cancer	0.000228	0.00333	CcSEcCtD
Mafenide—Pruritus—Gemcitabine—kidney cancer	0.000225	0.00329	CcSEcCtD
Mafenide—Diarrhoea—Gemcitabine—kidney cancer	0.000218	0.00318	CcSEcCtD
Mafenide—CA6—Metabolism—CCBL1—kidney cancer	0.000215	0.00252	CbGpPWpGaD
Mafenide—CA7—Metabolism—PDHB—kidney cancer	0.000214	0.0025	CbGpPWpGaD
Mafenide—Urticaria—Paclitaxel—kidney cancer	0.000212	0.00309	CcSEcCtD
Mafenide—Rash—Vincristine—kidney cancer	0.000212	0.00309	CcSEcCtD
Mafenide—Dermatitis—Vincristine—kidney cancer	0.000212	0.00309	CcSEcCtD
Mafenide—CA7—Metabolism—CCBL1—kidney cancer	0.000201	0.00235	CbGpPWpGaD
Mafenide—Rash—Gemcitabine—kidney cancer	0.000201	0.00293	CcSEcCtD
Mafenide—Dermatitis—Gemcitabine—kidney cancer	0.000201	0.00293	CcSEcCtD
Mafenide—Haemoglobin—Doxorubicin—kidney cancer	0.0002	0.00292	CcSEcCtD
Mafenide—Haemorrhage—Doxorubicin—kidney cancer	0.000199	0.0029	CcSEcCtD
Mafenide—CA12—Metabolism—PDHB—kidney cancer	0.000198	0.00231	CbGpPWpGaD
Mafenide—CA9—HIF-1-alpha transcription factor network—JUN—kidney cancer	0.000197	0.0023	CbGpPWpGaD
Mafenide—Pruritus—Paclitaxel—kidney cancer	0.000189	0.00276	CcSEcCtD
Mafenide—Pain—Capecitabine—kidney cancer	0.000187	0.00273	CcSEcCtD
Mafenide—CA6—Metabolism—PPAT—kidney cancer	0.000187	0.00218	CbGpPWpGaD
Mafenide—CA6—Metabolism—GLIPR1—kidney cancer	0.000187	0.00218	CbGpPWpGaD
Mafenide—CA12—Metabolism—CCBL1—kidney cancer	0.000186	0.00218	CbGpPWpGaD
Mafenide—Diarrhoea—Paclitaxel—kidney cancer	0.000183	0.00267	CcSEcCtD
Mafenide—CA2—Metabolism—ACY1—kidney cancer	0.000178	0.00208	CbGpPWpGaD
Mafenide—CA7—Metabolism—PPAT—kidney cancer	0.000174	0.00204	CbGpPWpGaD
Mafenide—CA7—Metabolism—GLIPR1—kidney cancer	0.000174	0.00204	CbGpPWpGaD
Mafenide—Urticaria—Capecitabine—kidney cancer	0.000174	0.00254	CcSEcCtD
Mafenide—CA6—Metabolism—FH—kidney cancer	0.000174	0.00203	CbGpPWpGaD
Mafenide—CA6—Metabolism—APRT—kidney cancer	0.000174	0.00203	CbGpPWpGaD
Mafenide—Erythema—Doxorubicin—kidney cancer	0.000173	0.00252	CcSEcCtD
Mafenide—CA9—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	0.000172	0.00201	CbGpPWpGaD
Mafenide—Rash—Paclitaxel—kidney cancer	0.000168	0.00246	CcSEcCtD
Mafenide—Dermatitis—Paclitaxel—kidney cancer	0.000168	0.00245	CcSEcCtD
Mafenide—CA6—Metabolism—GPC3—kidney cancer	0.000163	0.00191	CbGpPWpGaD
Mafenide—CA7—Metabolism—FH—kidney cancer	0.000162	0.00189	CbGpPWpGaD
Mafenide—CA7—Metabolism—APRT—kidney cancer	0.000162	0.00189	CbGpPWpGaD
Mafenide—CA12—Metabolism—GLIPR1—kidney cancer	0.000161	0.00189	CbGpPWpGaD
Mafenide—CA12—Metabolism—PPAT—kidney cancer	0.000161	0.00189	CbGpPWpGaD
Mafenide—CA6—Metabolism—CA2—kidney cancer	0.000159	0.00185	CbGpPWpGaD
Mafenide—Pruritus—Capecitabine—kidney cancer	0.000155	0.00226	CcSEcCtD
Mafenide—CA6—Metabolism—ALAD—kidney cancer	0.000155	0.00181	CbGpPWpGaD
Mafenide—CA7—Metabolism—GPC3—kidney cancer	0.000152	0.00178	CbGpPWpGaD
Mafenide—CA2—Metabolism—PDHB—kidney cancer	0.000151	0.00177	CbGpPWpGaD
Mafenide—CA6—Metabolism—ST3GAL2—kidney cancer	0.000151	0.00176	CbGpPWpGaD
Mafenide—CA9—Metabolism—ACY1—kidney cancer	0.00015	0.00175	CbGpPWpGaD
Mafenide—CA12—Metabolism—FH—kidney cancer	0.00015	0.00175	CbGpPWpGaD
Mafenide—CA12—Metabolism—APRT—kidney cancer	0.00015	0.00175	CbGpPWpGaD
Mafenide—Diarrhoea—Capecitabine—kidney cancer	0.00015	0.00219	CcSEcCtD
Mafenide—CA7—Metabolism—CA2—kidney cancer	0.000148	0.00173	CbGpPWpGaD
Mafenide—CA6—Metabolism—ALDH1A1—kidney cancer	0.000148	0.00172	CbGpPWpGaD
Mafenide—CA7—Metabolism—ALAD—kidney cancer	0.000144	0.00169	CbGpPWpGaD
Mafenide—CA2—Metabolism—CCBL1—kidney cancer	0.000142	0.00166	CbGpPWpGaD
Mafenide—CA6—Metabolism—PGK1—kidney cancer	0.000141	0.00165	CbGpPWpGaD
Mafenide—CA6—Metabolism—SLC5A3—kidney cancer	0.000141	0.00165	CbGpPWpGaD
Mafenide—CA12—Metabolism—GPC3—kidney cancer	0.000141	0.00165	CbGpPWpGaD
Mafenide—CA7—Metabolism—ST3GAL2—kidney cancer	0.000141	0.00165	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—GSTP1—kidney cancer	0.000139	0.00162	CbGpPWpGaD
Mafenide—CA6—Metabolism—LDHB—kidney cancer	0.000139	0.00162	CbGpPWpGaD
Mafenide—Rash—Capecitabine—kidney cancer	0.000138	0.00202	CcSEcCtD
Mafenide—Dermatitis—Capecitabine—kidney cancer	0.000138	0.00201	CcSEcCtD
Mafenide—CA7—Metabolism—ALDH1A1—kidney cancer	0.000138	0.00161	CbGpPWpGaD
Mafenide—CA12—Metabolism—CA2—kidney cancer	0.000137	0.0016	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—CDKN2B—kidney cancer	0.000135	0.00157	CbGpPWpGaD
Mafenide—CA12—Metabolism—ALAD—kidney cancer	0.000134	0.00156	CbGpPWpGaD
Mafenide—CA7—Metabolism—SLC5A3—kidney cancer	0.000132	0.00154	CbGpPWpGaD
Mafenide—CA7—Metabolism—PGK1—kidney cancer	0.000132	0.00154	CbGpPWpGaD
Mafenide—CA12—Metabolism—ST3GAL2—kidney cancer	0.000131	0.00153	CbGpPWpGaD
Mafenide—CA7—Metabolism—LDHB—kidney cancer	0.00013	0.00151	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—SOD2—kidney cancer	0.000128	0.0015	CbGpPWpGaD
Mafenide—CA9—Metabolism—PDHB—kidney cancer	0.000128	0.00149	CbGpPWpGaD
Mafenide—CA12—Metabolism—ALDH1A1—kidney cancer	0.000128	0.00149	CbGpPWpGaD
Mafenide—CA2—Metabolism—GLIPR1—kidney cancer	0.000123	0.00144	CbGpPWpGaD
Mafenide—CA2—Metabolism—PPAT—kidney cancer	0.000123	0.00144	CbGpPWpGaD
Mafenide—CA12—Metabolism—PGK1—kidney cancer	0.000122	0.00143	CbGpPWpGaD
Mafenide—CA12—Metabolism—SLC5A3—kidney cancer	0.000122	0.00143	CbGpPWpGaD
Mafenide—Pain—Doxorubicin—kidney cancer	0.000121	0.00176	CcSEcCtD
Mafenide—CA6—Metabolism—CA9—kidney cancer	0.00012	0.00141	CbGpPWpGaD
Mafenide—CA9—Metabolism—CCBL1—kidney cancer	0.00012	0.0014	CbGpPWpGaD
Mafenide—CA12—Metabolism—LDHB—kidney cancer	0.00012	0.0014	CbGpPWpGaD
Mafenide—CA2—Metabolism—APRT—kidney cancer	0.000115	0.00134	CbGpPWpGaD
Mafenide—CA2—Metabolism—FH—kidney cancer	0.000115	0.00134	CbGpPWpGaD
Mafenide—CA7—Metabolism—CA9—kidney cancer	0.000112	0.00131	CbGpPWpGaD
Mafenide—Urticaria—Doxorubicin—kidney cancer	0.000112	0.00164	CcSEcCtD
Mafenide—CA2—Metabolism—GPC3—kidney cancer	0.000108	0.00126	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—HIF1A—kidney cancer	0.000108	0.00126	CbGpPWpGaD
Mafenide—CA9—Metabolism—GLIPR1—kidney cancer	0.000104	0.00122	CbGpPWpGaD
Mafenide—CA9—Metabolism—PPAT—kidney cancer	0.000104	0.00122	CbGpPWpGaD
Mafenide—CA12—Metabolism—CA9—kidney cancer	0.000104	0.00122	CbGpPWpGaD
Mafenide—CA6—Metabolism—CRABP1—kidney cancer	0.000102	0.00119	CbGpPWpGaD
Mafenide—CA2—Metabolism—ALAD—kidney cancer	0.000102	0.00119	CbGpPWpGaD
Mafenide—CA2—Metabolism—ST3GAL2—kidney cancer	9.98e-05	0.00117	CbGpPWpGaD
Mafenide—Pruritus—Doxorubicin—kidney cancer	9.98e-05	0.00146	CcSEcCtD
Mafenide—CA2—Metabolism—ALDH1A1—kidney cancer	9.76e-05	0.00114	CbGpPWpGaD
Mafenide—CA9—Metabolism—FH—kidney cancer	9.67e-05	0.00113	CbGpPWpGaD
Mafenide—CA9—Metabolism—APRT—kidney cancer	9.67e-05	0.00113	CbGpPWpGaD
Mafenide—Diarrhoea—Doxorubicin—kidney cancer	9.65e-05	0.00141	CcSEcCtD
Mafenide—CA7—Metabolism—CRABP1—kidney cancer	9.55e-05	0.00112	CbGpPWpGaD
Mafenide—CA6—Metabolism—ITPR2—kidney cancer	9.51e-05	0.00111	CbGpPWpGaD
Mafenide—CA2—Metabolism—SLC5A3—kidney cancer	9.36e-05	0.00109	CbGpPWpGaD
Mafenide—CA2—Metabolism—PGK1—kidney cancer	9.36e-05	0.00109	CbGpPWpGaD
Mafenide—CA2—Metabolism—LDHB—kidney cancer	9.18e-05	0.00107	CbGpPWpGaD
Mafenide—CA9—Metabolism—GPC3—kidney cancer	9.1e-05	0.00106	CbGpPWpGaD
Mafenide—Rash—Doxorubicin—kidney cancer	8.9e-05	0.0013	CcSEcCtD
Mafenide—Dermatitis—Doxorubicin—kidney cancer	8.89e-05	0.0013	CcSEcCtD
Mafenide—CA7—Metabolism—ITPR2—kidney cancer	8.88e-05	0.00104	CbGpPWpGaD
Mafenide—CA12—Metabolism—CRABP1—kidney cancer	8.85e-05	0.00103	CbGpPWpGaD
Mafenide—CA9—Metabolism—CA2—kidney cancer	8.85e-05	0.00103	CbGpPWpGaD
Mafenide—CA6—Metabolism—ACHE—kidney cancer	8.67e-05	0.00101	CbGpPWpGaD
Mafenide—CA6—Metabolism—GSTT1—kidney cancer	8.67e-05	0.00101	CbGpPWpGaD
Mafenide—CA9—Metabolism—ALAD—kidney cancer	8.62e-05	0.00101	CbGpPWpGaD
Mafenide—CA9—Metabolism—ST3GAL2—kidney cancer	8.42e-05	0.000983	CbGpPWpGaD
Mafenide—CA9—Metabolism—ALDH1A1—kidney cancer	8.23e-05	0.000961	CbGpPWpGaD
Mafenide—CA12—Metabolism—ITPR2—kidney cancer	8.23e-05	0.000961	CbGpPWpGaD
Mafenide—CA6—Metabolism—SCARB1—kidney cancer	8.21e-05	0.000959	CbGpPWpGaD
Mafenide—CA6—Metabolism—PTGS1—kidney cancer	8.13e-05	0.000949	CbGpPWpGaD
Mafenide—CA7—Metabolism—GSTT1—kidney cancer	8.1e-05	0.000946	CbGpPWpGaD
Mafenide—CA7—Metabolism—ACHE—kidney cancer	8.1e-05	0.000946	CbGpPWpGaD
Mafenide—CA6—Metabolism—PSMD7—kidney cancer	7.97e-05	0.000931	CbGpPWpGaD
Mafenide—CA2—Metabolism—CA9—kidney cancer	7.96e-05	0.000929	CbGpPWpGaD
Mafenide—CA9—Metabolism—SLC5A3—kidney cancer	7.89e-05	0.000921	CbGpPWpGaD
Mafenide—CA9—Metabolism—PGK1—kidney cancer	7.89e-05	0.000921	CbGpPWpGaD
Mafenide—CA9—Metabolism—LDHB—kidney cancer	7.73e-05	0.000903	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—CDKN2A—kidney cancer	7.7e-05	0.0009	CbGpPWpGaD
Mafenide—CA7—Metabolism—SCARB1—kidney cancer	7.66e-05	0.000895	CbGpPWpGaD
Mafenide—CA7—Metabolism—PTGS1—kidney cancer	7.59e-05	0.000886	CbGpPWpGaD
Mafenide—CA6—Metabolism—BCHE—kidney cancer	7.56e-05	0.000883	CbGpPWpGaD
Mafenide—CA12—Metabolism—GSTT1—kidney cancer	7.5e-05	0.000876	CbGpPWpGaD
Mafenide—CA12—Metabolism—ACHE—kidney cancer	7.5e-05	0.000876	CbGpPWpGaD
Mafenide—CA6—Metabolism—SLC5A5—kidney cancer	7.46e-05	0.000872	CbGpPWpGaD
Mafenide—CA7—Metabolism—PSMD7—kidney cancer	7.44e-05	0.000869	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—RELA—kidney cancer	7.41e-05	0.000866	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—MTOR—kidney cancer	7.27e-05	0.000849	CbGpPWpGaD
Mafenide—CA6—Metabolism—SLC2A1—kidney cancer	7.21e-05	0.000842	CbGpPWpGaD
Mafenide—CA12—Metabolism—SCARB1—kidney cancer	7.1e-05	0.000829	CbGpPWpGaD
Mafenide—CA7—Metabolism—BCHE—kidney cancer	7.05e-05	0.000824	CbGpPWpGaD
Mafenide—CA12—Metabolism—PTGS1—kidney cancer	7.03e-05	0.000821	CbGpPWpGaD
Mafenide—CA7—Metabolism—SLC5A5—kidney cancer	6.97e-05	0.000814	CbGpPWpGaD
Mafenide—CA12—Metabolism—PSMD7—kidney cancer	6.89e-05	0.000805	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—CDKN1B—kidney cancer	6.82e-05	0.000797	CbGpPWpGaD
Mafenide—CA2—Metabolism—CRABP1—kidney cancer	6.76e-05	0.00079	CbGpPWpGaD
Mafenide—CA7—Metabolism—SLC2A1—kidney cancer	6.73e-05	0.000786	CbGpPWpGaD
Mafenide—CA12—Metabolism—BCHE—kidney cancer	6.53e-05	0.000763	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—JUN—kidney cancer	6.5e-05	0.000759	CbGpPWpGaD
Mafenide—CA12—Metabolism—SLC5A5—kidney cancer	6.45e-05	0.000754	CbGpPWpGaD
Mafenide—CA2—Metabolism—ITPR2—kidney cancer	6.29e-05	0.000735	CbGpPWpGaD
Mafenide—CA12—Metabolism—SLC2A1—kidney cancer	6.23e-05	0.000728	CbGpPWpGaD
Mafenide—CA6—Metabolism—GSTP1—kidney cancer	6.01e-05	0.000702	CbGpPWpGaD
Mafenide—CA2—Metabolism—ACHE—kidney cancer	5.73e-05	0.00067	CbGpPWpGaD
Mafenide—CA2—Metabolism—GSTT1—kidney cancer	5.73e-05	0.00067	CbGpPWpGaD
Mafenide—CA9—Metabolism—CRABP1—kidney cancer	5.7e-05	0.000666	CbGpPWpGaD
Mafenide—CA6—Metabolism—ABCB1—kidney cancer	5.69e-05	0.000665	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—VEGFA—kidney cancer	5.67e-05	0.000663	CbGpPWpGaD
Mafenide—CA7—Metabolism—GSTP1—kidney cancer	5.61e-05	0.000656	CbGpPWpGaD
Mafenide—CA6—Metabolism—GSTM1—kidney cancer	5.52e-05	0.000645	CbGpPWpGaD
Mafenide—CA2—Metabolism—SCARB1—kidney cancer	5.43e-05	0.000634	CbGpPWpGaD
Mafenide—CA2—Metabolism—PTGS1—kidney cancer	5.37e-05	0.000628	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—MAPK3—kidney cancer	5.37e-05	0.000627	CbGpPWpGaD
Mafenide—CA7—Metabolism—ABCB1—kidney cancer	5.31e-05	0.000621	CbGpPWpGaD
Mafenide—CA9—Metabolism—ITPR2—kidney cancer	5.3e-05	0.000619	CbGpPWpGaD
Mafenide—CA2—Metabolism—PSMD7—kidney cancer	5.27e-05	0.000616	CbGpPWpGaD
Mafenide—CA6—Metabolism—CYP1A1—kidney cancer	5.24e-05	0.000612	CbGpPWpGaD
Mafenide—CA12—Metabolism—GSTP1—kidney cancer	5.2e-05	0.000607	CbGpPWpGaD
Mafenide—CA7—Metabolism—GSTM1—kidney cancer	5.16e-05	0.000602	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—MAPK1—kidney cancer	5.11e-05	0.000597	CbGpPWpGaD
Mafenide—CA2—Metabolism—BCHE—kidney cancer	5e-05	0.000584	CbGpPWpGaD
Mafenide—CA2—Metabolism—SLC5A5—kidney cancer	4.93e-05	0.000576	CbGpPWpGaD
Mafenide—CA12—Metabolism—ABCB1—kidney cancer	4.92e-05	0.000575	CbGpPWpGaD
Mafenide—CA7—Metabolism—CYP1A1—kidney cancer	4.89e-05	0.000571	CbGpPWpGaD
Mafenide—CA9—Metabolism—GSTT1—kidney cancer	4.83e-05	0.000565	CbGpPWpGaD
Mafenide—CA9—Metabolism—ACHE—kidney cancer	4.83e-05	0.000565	CbGpPWpGaD
Mafenide—CA12—Metabolism—GSTM1—kidney cancer	4.78e-05	0.000558	CbGpPWpGaD
Mafenide—CA2—Metabolism—SLC2A1—kidney cancer	4.77e-05	0.000557	CbGpPWpGaD
Mafenide—CA9—Metabolism—SCARB1—kidney cancer	4.58e-05	0.000534	CbGpPWpGaD
Mafenide—CA9—Metabolism—PTGS1—kidney cancer	4.53e-05	0.000529	CbGpPWpGaD
Mafenide—CA12—Metabolism—CYP1A1—kidney cancer	4.53e-05	0.000529	CbGpPWpGaD
Mafenide—CA9—Metabolism—PSMD7—kidney cancer	4.44e-05	0.000519	CbGpPWpGaD
Mafenide—CA9—Cellular responses to stress—TP53—kidney cancer	4.29e-05	0.000501	CbGpPWpGaD
Mafenide—CA9—Metabolism—BCHE—kidney cancer	4.21e-05	0.000492	CbGpPWpGaD
Mafenide—CA9—Metabolism—SLC5A5—kidney cancer	4.16e-05	0.000486	CbGpPWpGaD
Mafenide—CA9—Metabolism—SLC2A1—kidney cancer	4.02e-05	0.000469	CbGpPWpGaD
Mafenide—CA2—Metabolism—GSTP1—kidney cancer	3.98e-05	0.000464	CbGpPWpGaD
Mafenide—CA6—Metabolism—POMC—kidney cancer	3.9e-05	0.000456	CbGpPWpGaD
Mafenide—CA2—Metabolism—ABCB1—kidney cancer	3.76e-05	0.00044	CbGpPWpGaD
Mafenide—CA2—Metabolism—GSTM1—kidney cancer	3.65e-05	0.000427	CbGpPWpGaD
Mafenide—CA7—Metabolism—POMC—kidney cancer	3.65e-05	0.000426	CbGpPWpGaD
Mafenide—CA2—Metabolism—CYP1A1—kidney cancer	3.46e-05	0.000404	CbGpPWpGaD
Mafenide—CA12—Metabolism—POMC—kidney cancer	3.38e-05	0.000394	CbGpPWpGaD
Mafenide—CA9—Metabolism—GSTP1—kidney cancer	3.35e-05	0.000391	CbGpPWpGaD
Mafenide—CA9—Metabolism—ABCB1—kidney cancer	3.17e-05	0.00037	CbGpPWpGaD
Mafenide—CA6—Metabolism—PTGS2—kidney cancer	3.11e-05	0.000364	CbGpPWpGaD
Mafenide—CA9—Metabolism—GSTM1—kidney cancer	3.08e-05	0.00036	CbGpPWpGaD
Mafenide—CA9—Metabolism—CYP1A1—kidney cancer	2.92e-05	0.000341	CbGpPWpGaD
Mafenide—CA7—Metabolism—PTGS2—kidney cancer	2.91e-05	0.00034	CbGpPWpGaD
Mafenide—CA6—Metabolism—PTEN—kidney cancer	2.72e-05	0.000317	CbGpPWpGaD
Mafenide—CA12—Metabolism—PTGS2—kidney cancer	2.69e-05	0.000315	CbGpPWpGaD
Mafenide—CA2—Metabolism—POMC—kidney cancer	2.58e-05	0.000302	CbGpPWpGaD
Mafenide—CA7—Metabolism—PTEN—kidney cancer	2.54e-05	0.000296	CbGpPWpGaD
Mafenide—CA12—Metabolism—PTEN—kidney cancer	2.35e-05	0.000274	CbGpPWpGaD
Mafenide—CA9—Metabolism—POMC—kidney cancer	2.18e-05	0.000254	CbGpPWpGaD
Mafenide—CA2—Metabolism—PTGS2—kidney cancer	2.06e-05	0.000241	CbGpPWpGaD
Mafenide—CA6—Metabolism—PIK3CA—kidney cancer	1.92e-05	0.000224	CbGpPWpGaD
Mafenide—CA2—Metabolism—PTEN—kidney cancer	1.8e-05	0.00021	CbGpPWpGaD
Mafenide—CA7—Metabolism—PIK3CA—kidney cancer	1.79e-05	0.000209	CbGpPWpGaD
Mafenide—CA9—Metabolism—PTGS2—kidney cancer	1.74e-05	0.000203	CbGpPWpGaD
Mafenide—CA12—Metabolism—PIK3CA—kidney cancer	1.66e-05	0.000194	CbGpPWpGaD
Mafenide—CA9—Metabolism—PTEN—kidney cancer	1.51e-05	0.000177	CbGpPWpGaD
Mafenide—CA2—Metabolism—PIK3CA—kidney cancer	1.27e-05	0.000148	CbGpPWpGaD
Mafenide—CA9—Metabolism—PIK3CA—kidney cancer	1.07e-05	0.000125	CbGpPWpGaD
